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Abstract 
Staphylococcus aureus is one of the main significant human pathogens which can produce various 
toxins such as Panton-Valentine Leukocidin (PVL) which is known as a prominent toxin associated 
with S. aureus infections. PVL-positive strains can cause a wide variety of skin, soft tissue, necrotiz-
ing pneumonia, fasciitis and life-threatening infections. Therefore, the aim of this study was evalu-
ating the molecular characteristics of PVL-positive strains such as the presence of mecA, SCCmec 
types, agr types and exfoliative toxin genes. In this study, a total of 152 S. aureus strains were col-
lected from clinical samples of patients who referred to Isfahan’s Alzahra hospital (Iran). The iso-
lates were confirmed phenotypically by conventional methods and then PVL-positive isolates were 
identified by PCR molecular test. Thereafter, antibiotic resistance pattern, agr groups (I, II, III, and 
IV), exfoliative toxins (eta and etb), mecA gene and SCCmec various types were carried out. Totally, 
52 (34.2%) of strains were positive for PVL. Six PVL-positive strains harbored mecA gene, one strain 
had SCCmec I, and 5 strains SCCmec type IV. The highest ratio of agr groups belonged to group (I) 
and the (eta) gene was also detected in 18 isolates. The PVL-positive S. aureus strains can cause 
more serious infections, so identification of the genetic characteristics and antibiotic resistance 
monitoring of these strains is necessary. 
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1. Introduction 
Staphylococcus aureus is one of the most 
important nosocomial pathogens which can 
cause a wide range of various clinical infections. 
Virulence factors and toxins produced by this 
bacterium are responsible for several infections 
in which, Pantone Valentine Leukocidin (PVL) 
and exfoliative toxins are the most relevant.  
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The PVL was first isolated from furuncles in 
1936 [1]. This toxin is composed of two subu-
nits, S and F which have synergistic activity by 
lukS-PV and lukF-PV genes [2, 3]. Injection of 
purified PVL, induces the liberating of hista-
mine from basophilic granulocytes, chemotactic 
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factors (leukotriene B4 & IL-8), oxygen metab-
olites of human neutrophilic granulocytes and 
enzymes [β-glucuronidase and lysozyme) [4]. 
In a mouse infection model, secreted PVL 
promotes tissue invasion, inflammatory 
response and necrotizing pneumonia, via mech-
anisms, including up-regulation of protein A 
and other adhesions [5]. The accessory gene 
regulatory system (agr) is responsible for regu-
lating the growth, colonization, the expression 
of exoenzymes, toxins, surface proteins and 
other virulence factors [6, 7]. This system also 
regulates the metabolic pathways of organisms 
as a contributing growth factor [8]. Although 
most human clinical S. aureus isolates are agr 
positive, while several reports indicate that the 
agr-defective mutants have been isolated from 
infected patients [8]. In the last two decades, 
the emergence of antibiotic-resistant strains, 
especially beta-lactam resistant has increased 
the clinical significance of S. aureus. The first 
case of methicillin-resistant S. aureus was de-
scribed in the UK [9]. Currently, the prevalence 
of methicillin-resistant Staphylococcus aureus 
(MRSA) in some regions is about 72 up to 90% 
[10]. The mecA gene, which is responsible for 
resistance to methicillin is carrying by a mobile 
genetic element, staphylococcal cassette chro-
mosome mec, (SCCmec) [9]. Cassette Chromo-
some Recombinase (ccr) is another important 
part of SCCmec, which is involved in the inser-
tion and exertion of SCCmec elements [11]. Un-
til now, by combining different classes of mec 
and ccr, at least 11 various types of SCCmec ele-
ments have been identified [12]. Type I, II and 
III are mainly associated with hospital-acquired 
MRSA (HA-MRSA), and types IV and V with 
Community-acquired MRSA (CA-MRSA) [13].  
Recently, PVL-positive S. aureus strains 
(PVL-SA) have attracted much attention, be-
cause of the critical role of PVL in clinical infec-
tions and emerging antibiotic-resistant strains. 
Therefore, the aim of this study was evaluating 
the molecular characteristics of PVL-positive 
strains such as the presence of mecA, SCCmec 
types, agr types and exfoliative toxin genes. 
2. Materials and Method 
2.1. Isolates collection and identification  
A total of non-duplicate 152 S. aureus 
strains were collected from different specimens 
such as abscess (28), wound (66),          respira-
tory tract infection (17), osteomyelitis (4), urine 
(16), a catheter (7) and bacteremia (14) from 
teaching hospitals of Isfahan, Iran. Isolates 
were confirmed by phenotypic tests (Gram 
staining, colony morphology on blood agar, 
mannitol salt agar, catalase, coagulase and 
DNase) and finally were stored at -20 ◦C in brain 
heart infusion broth (BHI) containing (12-15%) 
glycerol. 
2.2. Antibiotic resistance pattern 
Antimicrobial susceptibility testing was per-
formed using Gentamicin, Tetracycline, Ciprof-
loxacin, Cefoxitin, Rifampin, Trime-
thoprim/Sulfamethoxazole, Ampicillin and 
Clindamycin disks (HiMedia) according to CLSI 
standard guidelines [14]. S. aureus ATCC 25923 
and ATCC 33591 were used as negative and pos-
itive controls. 
2.3. DNA extraction 
The DNA was extracted using a genomic 
DNA purification kit (Fermentas, K0512) ac-
cording to the manufacturer protocol recom-
mendation. 
2.4. PCR Molecular test 
The PCR reactions were performed with 
specific primers that are shown in Table 1.The 
program of amplification were as follow: initial 
denaturation at 95 °C for 3 minutes, followed by 
35 cycles of denaturation at 95 °C for 45 sec-
onds, primer annealing based on references for 
30-45 seconds, extension at 72 °C for 45 sec-
onds, and a final extension at 72 °C for 7 
minutes. The homology sequence of agr and ex-
foliative products were sequenced and con-
firmed with the BLAST tools.  
3. Results 
Various specimens were collected during 
the sampling period of time. The highest num-
ber of strains was belonged to wound 66 
(43.4%) and abscess 28 (18.4%) samples. Anti-
microbial resistance patterns were determined 
by disk diffusion method. The most isolates 
were resistant to tetracycline (56.2%), 
clindamycin (35.6%) and ciprofloxacin (35.6%) 
whereas, there was a low resistance to gentami-
cin (Table 2). By using PCR method, 52 isolates 
(34.2%) harbored pvl gene. All PVL-SA were in-
vestigated for the presence of mecA, SCCmec 
types, exfoliative toxin and accessory regulatory 
genes. Among the PVL-SA, 18 (34.6%) strains 
harbored eta, 5 (9.6%) etb, and 2 (3.8%) strains 
carried both eta and etb genes. 
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Table1. The specific primers for amplification of pvl, eta, etb, agr, mecA and SCCmec type 
 

















On the other hand, the agr I, II, III, IV were 
recognized in 39 (75%), 3 (5.7%), 7 (13.5%) and 
3 (5.8%) isolates respectively. However, 46 
(88.5%) strains were MSSA and 6 (11.5%) 
strains were MRSA. Finally, SCCmec types I and 
IV, were determined in one and five. 
4. Discussion 
S. aureus is colonized in up to 25 percent of 
healthy people and even more common among 
those with skin, eye, throat and nasal mucosal 
surfaces. S. aureus is capable to produce various 
toxins in which, PVL is the most important one. 
The PVL-SA are more pathogenic in compari-
son with other strains and also can cause skin 
and soft tissue infections, but in some cases may 
lead  
 
to invasive infections including necrotizing 
hemorrhagic pneumonia [19]. Due to the im-
portance of these strains, evaluation of antibi-
otic resistance and genetic characteristics of 
PVL- positive strains could play an important 
role   in   determining   the   health   policy,   
hence, rapid detection and monitoring of PVL-
SA is necessary for appropriate treatments and 
can be helpful in epidemiologic studies. The 
prevalence of PVL-strains in Iran was reported 
18% in 2013, although the PVL-positive strains 
were distinguished among blood and urine 
specimens other samples were negative [20]. 
However, in 2014, Shrestha et al. reported that 
PVL was produced by 35.6% of S. aureus strains 
and was detected from bacteremia, surgical site, 
respiratory and urinary tract infection [2]. 
In the present study, 34.2% of the isolates 
were PVL-positive and the mentioned gene was 
isolated from respiratory tract infections, 
wound infections, abscess and osteomyelitis 
specimens. In addition, none of the blood-
stream and urine samples were harbored the 
pvl gene.  
The relation between PVL-SA and skin, soft 
tissue infections and necrotizing pneumonia 
has been demonstrated in several studies [2, 3, 
5]. Bocchini et al. (2017) reported that there was 
a correlation between PVL toxin production and 
the intensity of osteomyelitis [21]. 


















pan F ATGCACATGGTGCACATGC 
55 [17] 
I R GTCACAAGTACTATAAGCTGCGAT 
II R TATTACTAATTGAAAAGTGCCATAGC 
III R GTAATGTAATAGCTTGTATAATAATACCCAG 






β F ATTGCCTTGATAATAGCCYTCT 
52 [17] 
α3 R TAAAGGCATCAATGCACAAACACT 
ccrC F CGTCTATTACAAGATGTTAAGGATAAT 
ccrC R CCTTTATAGACTGGATTATTCAAAATAT 
1272 F GCCACTCATAACATATGGAA 
1272 R CATCCGAGTGAAACCCAAA 
5RmecA F TATACCAAACCCGACAACTAC 
5R431 R CGGCTACAGTGATAACATCC 
Antibiotics 
No. (%) of resistant strains  
Total No. =52 
Gentamycin 2 (3.8) 
Ciprofloxacin 5 (9.6) 
Ampicillin 3 (5.75) 
Clindamycin 6 (11.5) 
Tetracycline 15 (28.8) 
Co-trimoxazole 4 (7.6) 
Rifampicin 4 (7.6) 
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In our study, two PVL-positive strains were 
isolated from osteomyelitis. The osteomyelitis 
which is caused by PVL-SA is more complicated 
and similar to deep venous thrombosis or devel-
oped chronic osteomyelitis [21]. On the other 
hand, the pvl gene-positive MSSA contains a 
larger number of virulence factor genes in com-
parison to MRSA, although they are susceptible 
to more antimicrobial agents [22]. Numerous 
conducted studies have been demonstrated that 
the prevalence of PVL-positive strains among 
MSSA is more than MRSA strains [23, 24]. For 
instance, in two separate studies by Afroz et al. 
(2008) and Vorobieva et al. (2008), all PVL-
positive strains were methicillin-susceptible 
[23, 24]. The prevalence of PVL-positive strains, 
among MRSA strains in the UK and Greece, 
have been reported 1.6% and 45%, respectively. 
It seems MSSA strains are more involved in the 
spread of pvl genes among S. aureus strains.  
Karimi et al (2017) in Iran, verified that CA-
MRSA harbored SCCmec IV-V and pvl gene is 
widely associated with the presence of SCCmec 
IV-V [25]. Moreover, a relation among CA-
MRSA, SCCmec IV and PVL have been proved 
in study conducted by Shukla et al. (2004) [26]. 
Generally, from 40 to 90% of PVL-SA harbor 
SCCmec IV while, only 5% of PVL-positive 
strains have SCCmec I & III [9]. In our study 5 
(9.6%) of MRSA-PVL positive strains carried 
SCCmec IV and only 1 (1.9%) had SCCmec I.  
According to other virulence factors, Jar-
raud et al. (2000) investigated that each of the 
agr systems is responsible for regulating certain 
virulence genes and noted that TSST and exfoli-
ative producing strains mainly contain both agr 
group III and IV [27]. Several studies on PVL-
SA have shown that these strains do not belong 
to a specific agr group [28, 29]. 
In our study, 75% of PVL-SA had agr group 
I, while amongst MRSA strains, three strains 
had agr group III and other agr groups (I and 
IV). agr group III in some studies is regarded as 
the main one in MRSA-PVL positive strains 
[30]. It should be noted that agr group I was 
prevalent in most isolates, agr group II was 
dominant in nasal swabs (30%), agr group III 
was common in respiratory tract infections 
(26%), and agr group IV was higher in cutane-
ous isolates (12.1%) [31] 
Various reported on exfoliative toxin-
producing strains have suggested that the etb 
gene rate is lower than eta [32]. In a study per-
formed by Koosha et al (2014) in Tehran, 197 
isolates of S. aureus was investigated. The prev-
alence of eta and etb genes was reported 
(94.4%) and (7.6%), respectively [33]. Though 
in our study, the prevalence of eta gene was 
(34.6%), whereas etb was only (9.6%). 
In conclusion, our findings indicate the high 
prevalence of PVL-SA in clinical samples. Close 
surveillance of these strains is essential to 
monitoring their spread and antimicrobial re-
sistance profiles. Several studies show the in-
creasing importance of PVL-SA in nosocomial 
infections. Therefore, determining the fre-
quency of virulence factors and antibiotic re-
sistance profile can be useful in selecting the 
right therapeutic strategy. The indiscriminate 
usage of antibiotics, high ability to exchange ge-
netic elements and various types of resistance 
plasmids can multiply the importance of these 
pathogens. Our results emphasized that the sus-
ceptibility or resistance of S. aureus to antibiot-
ics commonly used in various geographical re-
gions is different. According to the increased re-
sistance of S. aureus to antibiotics, continuing 
control of antibiotic-resistant will prevent the 
emerging of drug-resistant strains. 
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